AMELIA PAULEY: Open Payments
NPI 1760973424 · OLNEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 14 payments from 9 companies in 2025. Trend: 2023 $171 · 2024 $220 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Alkermes, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Corium, LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: CAPLYTA, AUSTEDO XR, Auvelity, ARISTADA, ABILIFY MAINTENA, ICLUSIG, Azstarys, SPRAVATO.
Industry payments across IL — which companies pay providers there.
